Literature DB >> 22398801

Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.

Walter Ludwig Strohmaier1, Jürgen Seilnacht, Gernot Schubert.   

Abstract

BACKGROUND: Citrate is one of the most important inhibitors in urolithiasis. Hypocitraturia is a common risk factor in stone formers. Citrate excretion is regulated - amongst others - by acidosis and protein intake. A considerable number of stone formers, however, show hypocitraturia in the presence of normal urine pH levels. This is potentially due to defects in the renal tubular citrate carriers (NaDC 1 and 3) which may be genetically determined. PATIENTS AND METHODS: 350 consecutive stone formers were examined. Exclusion criteria were urinary tract infection, hypokalemia, and steatorrhea. The following parameters were measured: serum: creatinine, calcium, potassium, and uric acid; urine: pH profiles, citrate, calcium, uric acid, ammonia, urea, and creatinine.
RESULTS: 83/350 patients were hypocitraturic (48 males, 35 females). 14/83 had low urine pH (≤ 6), 69/83 showed normal levels (>6). In the latter group there was a significantly higher recurrence rate (23 vs. 9%). The two groups were not different in serum parameters apart from uric acid. In urine, only pH and calcium (males) were significantly lower in the first group. Citrate did not correlate with urine pH and creatinine in the hypocitraturia-normal pH group, only with calcium in both sexes and urea and ammonia in females. In the hypocitraturia-low pH patients, there was no significant correlation between citrate and any other parameter tested.
CONCLUSIONS: Hypocitraturia with normal urine pH is an entity indicating a high risk for recurrence. Since there was no correlation between citrate and pH, urea and ammonia, respectively, citrate excretion is not regulated in these patients as usual. There may be a link to calcium excretion. Potentially, these patients have defects in the renal tubular citrate carriers which may be genetically determined. Genetic examinations should be performed to elucidate a potential genetic disorder in hypocitraturia-normal pH stone formers.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398801     DOI: 10.1159/000335441

Source DB:  PubMed          Journal:  Urol Int        ISSN: 0042-1138            Impact factor:   2.089


  7 in total

1.  [Citrate salts for calcium containing kidney stones : Prevention and treatment].

Authors:  K Wilhelm
Journal:  Urologe A       Date:  2016-11       Impact factor: 0.639

2.  SLC26A6 and NaDC-1 transporters interact to regulate oxalate and citrate homeostasis.

Authors:  Ehud Ohana; Nikolay Shcheynikov; Orson W Moe; Shmuel Muallem
Journal:  J Am Soc Nephrol       Date:  2013-07-05       Impact factor: 10.121

3.  rs11567842 SNP in SLC13A2 gene associates with hypocitraturia in Thai patients with nephrolithiasis.

Authors:  Pattarin Udomsilp; Sarawut Saepoo; Rungnapa Ittiwut; Vorasuk Shotelersuk; Thasinas Dissayabutra; Chanchai Boonla; Piyaratana Tosukhowong
Journal:  Genes Genomics       Date:  2018-05-17       Impact factor: 1.839

4.  Demographic characteristics and metabolic risk factors in Croatian children with urolithiasis.

Authors:  Danko Milošević; Danica Batinić; Daniel Turudić; Danko Batinić; Marija Topalović-Grković; Ivan Pavao Gradiški
Journal:  Eur J Pediatr       Date:  2013-10-06       Impact factor: 3.183

5.  Evolution of bone mineral density in patients with idiopathic hypercalciuria: a 20-year longitudinal study.

Authors:  German Perez-Suarez; Ma Isabel Luis Yanes; Maria Cecilia Martín Fernández de Basoa; Elena Sánchez Almeida; Víctor M García Nieto
Journal:  Pediatr Nephrol       Date:  2020-09-26       Impact factor: 3.714

6.  Age-Specific Excretion of Calcium, Oxalate, Citrate, and Glycosaminoglycans and Their Ratios in Healthy Children and Children with Urolithiasis.

Authors:  Daniel Turudic; Anja Tea Golubic; Mila Lovric; Marko Bilic; Danko Milosevic
Journal:  Biomolecules       Date:  2021-05-19

Review 7.  Nutrition in calcium nephrolithiasis.

Authors:  Elena Dogliotti; Giuseppe Vezzoli; Antonio Nouvenne; Tiziana Meschi; Annalisa Terranegra; Alessandra Mingione; Caterina Brasacchio; Benedetta Raspini; Daniele Cusi; Laura Soldati
Journal:  J Transl Med       Date:  2013-05-01       Impact factor: 5.531

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.